These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12004281)

  • 1. Rapid progression of CD4 cell decline and subsequent response to salvage therapy in HIV-2 infection.
    Houston SC; Miedzinski LJ; Mashinter LD
    AIDS; 2002 May; 16(8):1189-91. PubMed ID: 12004281
    [No Abstract]   [Full Text] [Related]  

  • 2. Foscarnet used in salvage therapy of HIV-1 patients harbouring multiple nucleotide excision mutations.
    Mathiesen S; Roge BT; Weis N; Lundgren JD; Obel N; Gerstoft J
    AIDS; 2004 Apr; 18(7):1076-8. PubMed ID: 15096815
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient.
    Wandeler G; Furrer H; Rauch A
    AIDS; 2011 Nov; 25(18):2306-8. PubMed ID: 22067200
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.
    Ekouévi DK; Avettand-Fènoël V; Tchounga BK; Coffie PA; Sawadogo A; Minta D; Minga A; Eholie SP; Plantier JC; Damond F; Dabis F; Rouzioux C;
    PLoS One; 2015; 10(6):e0129886. PubMed ID: 26111242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy for HIV-2 infected patients.
    Smith NA; Shaw T; Berry N; Vella C; Okorafor L; Taylor D; Ainsworth J; Choudhury A; Daniels RS; El-Gadi S; Fakoya A; Moyle G; Oxford J; Tedder R; O'Shea S; de Ruiter A; Breuer J
    J Infect; 2001 Feb; 42(2):126-33. PubMed ID: 11531319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ritonavir-saquinavir rescue therapy in HIV-positive patients failing with indinavir, rotinavir or saquinavir.
    De Wit S; Cassano P; Hermans P; Sommereijns B; Kabeya K; O'Doherty E; Clumeck N
    AIDS; 1999 Sep; 13(13):1794-5. PubMed ID: 10509591
    [No Abstract]   [Full Text] [Related]  

  • 7. Higher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123--ETOILE).
    Avettand-Fenoel V; Bouteloup V; Mélard A; Fagard C; Chaix ML; Leclercq P; Chêne G; Viard JP; Rouzioux C;
    J Antimicrob Chemother; 2010 Oct; 65(10):2212-4. PubMed ID: 20667886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
    Clark NM; Dieng Sarr A; Sankalé JL; Kanki PJ; Kazanjian P; Winfield R; Markovitz DM
    AIDS; 1998 Dec; 12(18):2506-7. PubMed ID: 9875594
    [No Abstract]   [Full Text] [Related]  

  • 9. Salvage therapy.
    Gazzard B
    J HIV Ther; 2005 Mar; 10(1):3-5. PubMed ID: 15951727
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in plasma HIV-RNA and CD4 lymphocyte counts in patients receiving highly active antiretroviral therapy.
    Maggiolo F; Bottura P; Capra R; Pirali A; Zaffaroni P; Suter F
    AIDS; 1999 Aug; 13(12):1594-5. PubMed ID: 10465093
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of response (CD4 cell count and viral load) at 6 months in HIV-infected patients on highly active antiretroviral therapy.
    Barreiro PM; Dona MC; Castilla J; Soriano V
    AIDS; 1999 Mar; 13(4):525-6. PubMed ID: 10197384
    [No Abstract]   [Full Text] [Related]  

  • 12. [Viral load and CD4+ lymphocyte count in the era of highly active antiretroviral therapy].
    Martín JC; Fernández P; Soriano V; Martínez P; González-Lahoz J
    Med Clin (Barc); 2000 Jun; 115(3):118. PubMed ID: 10965488
    [No Abstract]   [Full Text] [Related]  

  • 13. Virological and immunological outcomes of elvitegravir-based regimen in a treatment-naïve HIV-2-infected patient.
    Zheng Y; Lambert C; Arendt V; Seguin-Devaux C
    AIDS; 2014 Sep; 28(15):2329-31. PubMed ID: 25313590
    [No Abstract]   [Full Text] [Related]  

  • 14. Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
    Delory T; Papot E; Rioux C; Charpentier C; Auge-Courtoi C; Michard F; Peytavin G; Descamps D; Matheron S; Yazdanpanah Y
    J Med Virol; 2016 Jul; 88(7):1204-10. PubMed ID: 26636432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interruptions may be beneficial.
    AIDS Patient Care STDS; 2002 Oct; 16(10):512. PubMed ID: 12442736
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-HIV agents. Rescue therapy.
    TreatmentUpdate; 2000 Mar; 12(2):5-6. PubMed ID: 12125620
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy for early HIV infection: how far back should the pendulum swing?
    Schechter M
    J Infect Dis; 2004 Sep; 190(6):1043-5. PubMed ID: 15319851
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count.
    Montaner JS; DeMasi R; Hill AM
    AIDS; 1998 Mar; 12(5):F23-8. PubMed ID: 9543436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking STIs, revamping salvage, revisiting toxicity (or, the clouds of chronicity). 11th conference on retroviruses and opportunistic infections. February 8-11, 2004, San Francisco.
    Mascolini M
    IAPAC Mon; 2004 May; 10(5):154-76. PubMed ID: 15366102
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term maraviroc use as salvage therapy in HIV-2 infection.
    Caixas U; Ferreira J; Marinho AT; Faustino I; Grilo NM; Lampreia F; Germano I; Monteiro EC; Pereira SA
    J Antimicrob Chemother; 2012 Oct; 67(10):2538-9. PubMed ID: 22729923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.